This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welling, M. M.
Right arrow Articles by Amerongen, A. V. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welling, M. M.
Right arrow Articles by Amerongen, A. V. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2007, p. 3416-3419, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00196-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Histatin-Derived Monomeric and Dimeric Synthetic Peptides Show Strong Bactericidal Activity towards Multidrug-Resistant Staphylococcus aureus In Vivo{triangledown}

Mick M. Welling,1* Carlo P. J. M. Brouwer,2 Wim van 't Hof,3 Enno C. I. Veerman,3 and Arie V. Nieuw Amerongen3

Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden, the Netherlands,1 R&D, AM-Pharma, Bunnik, the Netherlands,2 Academic Centre for Dentistry Amsterdam (ACTA), Department of Oral Biochemistry, Amsterdam, the Netherlands3

Received 9 February 2007/ Returned for modification 4 April 2007/ Accepted 27 June 2007

Homodimerization of histatin-derived peptides generally led to improved bactericidal activity against Staphylococcus aureus in vitro. In vivo, monomers and dimers were equally active in killing bacteria in mice with a soft tissue infection. Altogether, these peptides are promising compounds for the development of novel therapeutics against infections with drug-resistant bacteria.


* Corresponding author. Mailing address: Section Nuclear Medicine, Division of Radiology, Leiden University Medical Center, Room C4-R-77, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Phone: 31 71 5261880. Fax: 31 71 5266751. E-mail: m.m.welling{at}lumc.nl

{triangledown} Published ahead of print on 9 July 2007.


Antimicrobial Agents and Chemotherapy, September 2007, p. 3416-3419, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00196-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.